Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis

Program Description

Allergic conjunctivitis is a common, noninfectious inflammation of the conjunctiva, the clear tissue covering the white parts of the eyes, that often coexists with allergic rhinitis and asthma, significantly impacting quality of life. Most cases can be managed in an outpatient setting by identifying and avoiding allergens, using nonpharmacologic approaches, and progressing to OTC ophthalmic treatments as needed. However, allergic conjunctivitis is frequently self-diagnosed or misdiagnosed, which results in suboptimal management. Pharmacists and pharmacy technicians, often the first point of contact for patients, play a crucial role in sharing education on the condition and treatment. This activity will review symptomatology, pathophysiology, and treatment recommendations. After participating, pharmacists and pharmacy technicians will be better equipped to provide accurate information and effective care, ultimately improving patient outcomes.

Target audience: Community pharmacists
Type of activity: Application
Release date: April 7, 2025
Expiration date: April 7, 2026
Learner level: Foundational
Time to complete activity: 2.0 hours
Fee: Free

Pharmacist Educational Objectives
At the completion of this activity, participants will be able to:

• Explain the characteristics, symptoms, and allergens involved in seasonal and perennial allergic conjunctivitis
• Distinguish the active ingredients, modes of action, and timing of various OTC ophthalmic medications for allergic conjunctivitis
• Identify patients for suitable OTC treatments tailored to specific allergic conjunctivitis symptoms and personal factors

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity numbers 0290-0000-25-047-H01-P and 0290-0000-25-047-H01-T. The activity is available for CE credit through April 7, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Andrew Straw, PharmD, BCADM

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Liza Patel, PharmD, RPh; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green

Pharmacy Times® Editorial Staff— Aislinn Antrim

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms